Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Clinical Trial to Evaluate Ganovo（Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection

NCT04291729 is registered in ClinicalTrials.gov with The Ninth Hospital of Nanchang as lead sponsor.

NCT NCT04291729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04291729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Clinical Trial to Evaluate Ganovo（Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection
Lead sponsor
The Ninth Hospital of Nanchang
Phase
Phase 4
Overall status
Completed
Start date
February 17, 2020
Completion date
March 19, 2020
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19